Preview this article 1 min Harmony Biosciences also raised its overall 2025 revenue guidance. The State of Biotech Industry: ...

Ventyx Biosciences, Inc. surged after strong Phase 2 results for VTX3232 in obesity. Click for key insights and what VTYX ...

A biology teacher has become the first patient in the UK to receive a "gamechanger" therapy to treat multiple sclerosis (MS).

The consensus price target hints at a 50.1% upside potential for Castle Biosciences (CSTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...

An international research team has determined the first high-resolution structures of the herpes simplex virus origin-binding ...

VTX3232 demonstrated significant reductions in cardiovascular risk factors, with additional benefits when combined with semaglutide VTX3232 monotherapy achieved ~80% reduction in hsCRP within the firs ...

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, ...

The most recent analyst rating on (ENVB) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Enveric Biosciences stock, see the ENVB Stock Forecast page. According ...

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a ...

Over 100 videos of venomous snake strikes reveal three different types of attacks, with some biting down several times "to prolong the venom flow into their prey." ...

MOULTONBOROUGH —Moultonborough Public Library will host local birder and naturalist Steve Hale on Tuesday, Nov. 4, at 6 p.m. who will present an engaging and informative talk on Winter Backyard ...